Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aymard

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
Bulletin of the World Health Organization|January 1, 1984
Antigenic comparisons of swine-influenza-like H1N1 isolates from pigs, birds and humans: an international collaborative studyV S Hinshaw, D J Alexander, M Aymard, et al.
Transplantation Proceedings|October 1, 1996
Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trialC Pouteil-Noble, F Megas, F Chapuis, et al.
Journal of Medical Virology|May 1, 1997
Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cellsL Mallet, F Pelloquin, M Brigaud, et al.
The Laryngoscope|February 2, 2019
Long-term quality of life after definitive treatment of sinonasal and nasopharyngeal malignanciesMatthew A Tyler, Abdallah S R Mohamed, Joshua B Smith, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Gene therapy with AdV-IL2 (TG 1021) in unresectable digestive adenocarcinoma. Phase I-II study, first inclusionsF N Gilly, A C Sayag-Beaujard, J Bienvenu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2000
Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantationY Chen, C Scieux, V Garrait, et al.
Hepato-Gastroenterology|August 3, 1999
Gene therapy with Adv-IL-2 in unresectable digestive cancer: phase I-II study, intermediate reportF N Gilly, A Beaujard, J Bienvenu, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1996
[Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis]G Bellon, L Calmard, D Thouvenot, et al.
Human Gene Therapy|January 1, 1997
Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trialG Bellon, L Michel-Calemard, D Thouvenot, et al.
Journal of Clinical Microbiology|January 13, 2004
Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-upC Danve-Szatanek, M Aymard, D Thouvenot, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Bulletin of the World Health Organization|January 1, 1984
Antigenic comparisons of swine-influenza-like H1N1 isolates from pigs, birds and humans: an international collaborative studyV S Hinshaw, D J Alexander, M Aymard, et al.
Transplantation Proceedings|October 1, 1996
Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trialC Pouteil-Noble, F Megas, F Chapuis, et al.
Journal of Medical Virology|May 1, 1997
Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cellsL Mallet, F Pelloquin, M Brigaud, et al.
The Laryngoscope|February 2, 2019
Long-term quality of life after definitive treatment of sinonasal and nasopharyngeal malignanciesMatthew A Tyler, Abdallah S R Mohamed, Joshua B Smith, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Gene therapy with AdV-IL2 (TG 1021) in unresectable digestive adenocarcinoma. Phase I-II study, first inclusionsF N Gilly, A C Sayag-Beaujard, J Bienvenu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2000
Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantationY Chen, C Scieux, V Garrait, et al.
Hepato-Gastroenterology|August 3, 1999
Gene therapy with Adv-IL-2 in unresectable digestive cancer: phase I-II study, intermediate reportF N Gilly, A Beaujard, J Bienvenu, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1996
[Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis]G Bellon, L Calmard, D Thouvenot, et al.
Human Gene Therapy|January 1, 1997
Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trialG Bellon, L Michel-Calemard, D Thouvenot, et al.
Journal of Clinical Microbiology|January 13, 2004
Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-upC Danve-Szatanek, M Aymard, D Thouvenot, et al.
Pageof 19